Mainz Biomed N.V.
MYNZ
$1.59
-$0.02-1.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 0.00% | 21.48% | 0.00% | 3.60% | 0.00% |
| Total Depreciation and Amortization | 0.00% | -3.85% | 0.00% | 4.63% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 0.00% | -18.65% | 0.00% | 2.88% | 0.00% |
| Change in Net Operating Assets | 0.00% | 81.55% | 0.00% | -192.16% | 0.00% |
| Cash from Operations | 0.00% | 27.15% | 0.00% | -9.83% | 0.00% |
| Capital Expenditure | 0.00% | -107.59% | 0.00% | 113.10% | 0.00% |
| Sale of Property, Plant, and Equipment | -- | -- | 0.00% | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | 0.00% | -- | -- |
| Other Investing Activities | 0.00% | -400.00% | 0.00% | 150.00% | 0.00% |
| Cash from Investing | 0.00% | -303.43% | 0.00% | 152.73% | 0.00% |
| Total Debt Issued | -- | -- | 0.00% | -54.88% | 0.00% |
| Total Debt Repaid | 0.00% | -58.80% | 0.00% | 42.06% | 0.00% |
| Issuance of Common Stock | 0.00% | -73.32% | 0.00% | 2,471.70% | 0.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 0.00% | -80.96% | 0.00% | 450.62% | 0.00% |
| Foreign Exchange rate Adjustments | 0.00% | 51.04% | 0.00% | 15.19% | 0.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 0.00% | -182.25% | 0.00% | 186.29% | 0.00% |